0001209191-18-012450.txt : 20180222
0001209191-18-012450.hdr.sgml : 20180222
20180222163600
ACCESSION NUMBER: 0001209191-18-012450
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180220
FILED AS OF DATE: 20180222
DATE AS OF CHANGE: 20180222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Richard John P
CENTRAL INDEX KEY: 0001296528
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51173
FILM NUMBER: 18633065
MAIL ADDRESS:
STREET 1: 260 LITTLEFIELD AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATALYST BIOSCIENCES, INC.
CENTRAL INDEX KEY: 0001124105
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 562020050
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 260 LITTLEFIELD AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 6507450655
MAIL ADDRESS:
STREET 1: 260 LITTLEFIELD AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: TARGACEPT INC
DATE OF NAME CHANGE: 20000919
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-02-20
0
0001124105
CATALYST BIOSCIENCES, INC.
CBIO
0001296528
Richard John P
611 GATEWAY BLVD., SUITE 710
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Redeemable Convertible Note
137.85
2018-02-20
4
J
0
16559.00
0.00
D
Common Stock
120
0.00
D
Reflects a 1:15 reverse stock split effected on February 10, 2017.
Reflects a redeemable convertible note of the Issuer (the "Note") that matured, with the face value of the Note repaid to the Reporting Person.
At the option of the Reporting Person, at any time on or before February 19, 2018, the Note was redeemable into cash at a rate of $1 for each $1 principal amount of the Note or convertible into shares of common stock of the Issuer at a conversion rate of $137.85 per share, respectively.
The Note matured on February 19, 2018.
/s/ Faisal Shawwa, Attorney-in-Fact for John P. Richard
2018-02-22